TrademarkOpen
Search / United States / 88838607

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

APIJECT

Registered
Used for: Syringes sold filled with pharmaceuticals, namely, pharmaceutical preparations for treating infectious diseases…
Show more

Class 5: Syringes sold filled with pharmaceuticals, namely, pharmaceutical preparations for treating infectious diseases, diabetes, parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations and chromosomal abnorm…
Class 10: Syringes for medical purposes
Class 35: Promoting public awareness in the field of health, infectious diseases, emergency response and vaccine delivery; Promoting public awareness in the field of health, infectious diseases, emergency response and vaccine delivery by means of public advocacy

Class 5 – Pharmaceuticals & supplementsClass 10 – Medical apparatusClass 35 – Advertising & retail

Status timeline

  1. 21 Mar 2020
    Application filed
    New Application Entered
  2. 9 Jun 2020
    Assigned to an examining attorney
    Assigned To Examiner
  3. 11 Jun 2020
    Office action issued
    Non-Final Action Written
  4. 10 Dec 2020
    Approved for publication
    Approved For Pub - Principal Register
  5. 10 Dec 2020
    Response to office action filed
    Teas Response To Office Action Received
  6. 12 Jan 2021
    Published for opposition
    Published For Opposition
  7. 9 Mar 2021
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 8 Sep 2021
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 10 Feb 2022
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 25 May 2022
    Assigned to an examining attorney
    Assigned To Examiner
  11. 22 Aug 2022
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
  12. 21 Feb 2023
    Assigned to an examining attorney
    Assigned To Examiner
  13. 11 Mar 2024
    Statement of use filed
    Teas Statement Of Use Received
  14. 9 Apr 2024
    Office action issued
    Non-Final Action Written
  15. 29 May 2024
    Assigned to an examining attorney
    Assigned To Examiner
  16. 7 Jul 2024
    Response to office action filed
    Teas Response To Office Action Received
  17. 18 Oct 2024
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  18. 3 Dec 2024
    Registered on the Principal Register
    Registered-Principal Register
All 61 events
2025-11-06Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2025-11-06Attorney/Dom.rep.revoked And/Or Appointed
2025-11-06Teas Change Of Correspondence Received
2025-01-03Teas Change Of Correspondence Received
2024-12-03Registered-Principal Register
2024-12-03Notice Of Registration Confirmation Emailed
2024-10-18Assigned To Lie
2024-10-18Correspondence Received In Law Office
2024-10-18Teas/Email Correspondence Entered
2024-10-18Allowed Principal Register - Sou Accepted
2024-10-18Notice Of Acceptance Of Statement Of Use E-Mailed
2024-07-07Teas Response To Office Action Received
2024-05-29Assigned To Examiner
2024-04-09Non-Final Action Written
2024-04-09Non-Final Action E-Mailed
2024-04-09Notification Of Non-Final Action E-Mailed
2024-03-14Statement Of Use Processing Complete
2024-03-11Teas Statement Of Use Received
2024-03-11Use Amendment Filed
2023-09-08Notice Of Approval Of Extension Request E-Mailed
2023-09-07Case Assigned To Intent To Use Paralegal
2023-09-07Sou Extension 5 Granted
2023-08-28Sou Teas Extension Received
2023-08-28Sou Extension 5 Filed
2023-02-28Notice Of Approval Of Extension Request E-Mailed
2023-02-26Sou Teas Extension Received
2023-02-26Sou Extension 4 Filed
2023-02-26Sou Extension 4 Granted
2023-02-21Assigned To Examiner
2022-08-24Notice Of Approval Of Extension Request E-Mailed
2022-08-22Sou Teas Extension Received
2022-08-22Sou Extension 3 Filed
2022-08-22Sou Extension 3 Granted
2022-05-25Assigned To Examiner
2022-02-12Notice Of Approval Of Extension Request E-Mailed
2022-02-10Sou Teas Extension Received
2022-02-10Sou Extension 2 Filed
2022-02-10Sou Extension 2 Granted
2021-09-10Notice Of Approval Of Extension Request E-Mailed
2021-09-08Sou Teas Extension Received
2021-09-08Sou Extension 1 Filed
2021-09-08Sou Extension 1 Granted
2021-08-31Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2021-08-31Attorney/Dom.rep.revoked And/Or Appointed
2021-08-31Teas Change Of Correspondence Received
2021-03-09Noa Mailed - Sou Required From Applicant
2021-01-12Published For Opposition
2021-01-12Official Gazette Publication Confirmation E-Mailed
2020-12-23Notification Of Notice Of Publication E-Mailed
2020-12-10Examiners Amendment -Written
2020-12-10Examiners Amendment E-Mailed
2020-12-10Notification Of Examiners Amendment E-Mailed
2020-12-10Examiner's Amendment Entered
2020-12-10Approved For Pub - Principal Register
2020-12-10Teas Response To Office Action Received
2020-06-11Non-Final Action Written
2020-06-11Non-Final Action E-Mailed
2020-06-11Notification Of Non-Final Action E-Mailed
2020-06-09Assigned To Examiner
2020-03-22New Application Office Supplied Data Entered
2020-03-21New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Syringes sold filled with pharmaceuticals, namely, pharmaceutical preparations for treating infectious diseases, diabetes, parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations and chromosomal abnorm…

First use anywhere 3 Mar 2022 · First use in commerce 5 Mar 2024

Class 10 Medical apparatus

Syringes for medical purposes

First use anywhere 3 Mar 2022 · First use in commerce 1 Jun 2023

Class 35 Advertising & retail

Promoting public awareness in the field of health, infectious diseases, emergency response and vaccine delivery; Promoting public awareness in the field of health, infectious diseases, emergency response and vaccine delivery by means of public advocacy

First use anywhere 3 Mar 2022 · First use in commerce 29 Nov 2023

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 6 Nov 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.